← Leaderboards
Robert W Simms
Boston University Medical Campus
$2,168,460
Attributed
$2,168,460
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.7M · FY2011–15$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$4,398,916 · 4
By mechanism
P50$3,760,925 · 2
P30$607,504 · 1
M01$30,487 · 1
Top collaborators
- Robert A Lafyatis2 shared
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Robert A Lafyatis$10,905,922
- Maria Trojanowska$16,742,564
- Benjamin L Wolozin$31,159,035
- Alpaslan Dedeoglu$7,018,151
- Douglas L Rosene$20,446,719
Others in their field
Top investigators on “Complex”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$385,971,304
- Chanza Baytop · Westat, Inc.$271,217,917
- David R. Weir · University Of Michigan At Ann Arbor$186,776,551
- Barton F Haynes · Duke University$162,931,717
Research focus
ComplexFibrosisPulmonary Arterial HypertensionSkinSclerodermaPathogenesisDisease ProgressionEndothelial CellsBlood VesselsClinical DataBiopsyResourcesSamplingEvaluationGene ExpressionDatabasesGenesNational Institute Of Arthritis And Musculoskeletal And Skin DiseasesCollectionInterstitial Lung DiseasesMortality Vital StatisticsPeripheral Blood Mononuclear CellResearch PersonnelTissue Sample
Grant awards (8)
NIAMS: CORT$1,622,952
P50 · FY2015 · AR · contact PI
Rheumatic Diseases Research Core Centers$607,504
P30 · FY2015 · AR · contact PI
Core B Clinical Core$463,377
P50 · FY2015 · AR · contact PI
Core B Clinical Core$450,090
P50 · FY2014 · AR · contact PI
Core B Clinical Core$387,458
P50 · FY2013 · AR · contact PI
Core B Clinical Core$403,692
P50 · FY2012 · AR · contact PI
Core B Clinical Core$433,356
P50 · FY2011 · AR · contact PI
INFUSION OF RECOMBINANT HUMAN RELAXIN IN PATIENTS W/ SCLERODERMA$30,487
M01 · FY2000 · RR